id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0802-0039,FDA,FDA-2011-N-0802,Exploring Naloxone Uptake and Use; Public Meeting; Request for Comments,Notice,Meeting,2015-05-19T04:00:00Z,2015,5,2015-05-19T04:00:00Z,2015-09-02T03:59:59Z,2015-09-02T01:30:48Z,2015-12061,0,0,0900006481ae8057
FDA-2011-N-0802-0001,FDA,FDA-2011-N-0802,Role of Naloxone in OpioidOverdose Fatality Prevention; Workshop; Request for Comments,Notice,Meeting,2011-11-17T05:00:00Z,2011,11,2011-11-17T05:00:00Z,2012-06-13T03:59:59Z,2012-06-14T02:02:30Z,2011-29703,0,0,0900006480f6e632